Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent

Fludarabine: a new agent with major activity against chronic lymphocytic leukemia

1989 • 466 citations

Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group

1988 • 415 citations

Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.

1991 • 255 citations

2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia

1988 • 237 citations

Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.

1988 • 192 citations

Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis [see comments]

1992 • 176 citations

Malignant lymphoma supervening in chronic lymphocytic leukemia and related disorders. Richter's syndrome: A study of 25 cases

1981 • 166 citations

POTENTIAL ANTICANCER AGENTS.¹ XL. SYNTHESIS OF THE β-ANOMER OF 9-(D-ARABINOFURANOSYL)-ADENINE

1960 • 165 citations

Low-dose deoxycoformycin in lymphoid malignancy.

1985 • 149 citations

Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial.

1991 • 134 citations

Response to 2-Chlorodeoxyadenosine in Patients with B-Cell Chronic Lymphocytic Leukemia Resistant to Fludarabine

1992 • 130 citations

Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisone

1985 • 130 citations

2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia

1991 • 123 citations

2-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive Nucleoside

1991 • 100 citations

Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone).

1982 • 93 citations

Phase II trial of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in non-Hodgkin's lymphoma: prospective comparison of response with deoxycytidine kinase activity.

1987 • 92 citations

Effects on human peripheral lymphocytes of in vivo administration of 9-beta-D-arabinofuranosyl-2-fluoroadenine-5'-monophosphate (NSC 312887), a new purine antimetabolite.

1984 • 89 citations

A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia.

1991 • 83 citations

Multiple agent chemotherapy (POACH) in previously treated and untreated patients with chronic lymphocytic leukemia.

1988 • 71 citations

[Richter's syndrome].

1971 • 44 citations

Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in the treatment of refractory chronic lymphocytic leukemia.

1979 • 40 citations

Treatment of chronic lymphocytic leukemia using chlorambucil and prednisone with or without cycle-active consolidation chemotherapy .A southeastern cancer study group trial

1986 • 39 citations

Kinetics of Recovery of CD4+ T Cells in Peripheral Blood of Deoxycoformycin-Treated Patients

1991 • 39 citations

A randomized trial comparing chlorambucil plus prednisone vs cyclophosphamide, melphalan, and prednisone in the treatment of chronic lymphocytic leukemia stages B and C.

1988 • 33 citations